Predictors of Compliance with Muscle Invasive Bladder Cancer Quality Measures and its Effect on Survival Outcomes
Date
2021Author
Lee, Daniel J.
Barocas, Daniel A.
Demirdag, Cetin
Keegan, Kirk A.
Joyce, Daniel D.
Metadata
Show full item recordAbstract
Introduction: To assess and improve quality of care, the Commission on Cancer developed 3 evidence-based quality measures for the treatment of muscle invasive bladder cancer. We sought to assess performance of these measures prior to their implementation, whether compliance was associated with survival and whether patient factors influenced compliance.
Collections
- Makale [92796]